Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Heidemann

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|August 23, 2000
WHO consensus conference on diet and cancer. Members of the breast cancer panelF L Meyskens, W F Jungi, M Gerber, et al.
Atherosclerosis|March 23, 2022
Genetic variants associated with low-density lipoprotein cholesterol and systolic blood pressure and the risk of recurrent cardiovascular disease in patients with established vascular diseaseEline H Groenland, Britt E Heidemann, Sander W van der Laan, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2002
Primary breast cancer therapy in six regions of GermanyJ Engel, G Nagel, E Breuer, et al.
Breast Cancer Research and Treatment|December 10, 2015
Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotypeWerner Schroth, S Winter, F Büttner, et al.
Clinical Genetics|July 5, 2022
Establishing the relationship between familial dysbetalipoproteinemia and genetic variants in the APOE geneBritt E Heidemann, Charlotte Koopal, Alexis Baass, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trialE Heidemann, H Stoeger, R Souchon, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 9, 2022
Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol measurement in Familial DysbetalipoproteinemiaBritt E Heidemann, Charlotte Koopal, Jeanine E Roeters van Lennep, et al.
Journal of Clinical Lipidology|November 17, 2022
Effect of evolocumab on fasting and post fat load lipids and lipoproteins in familial dysbetalipoproteinemiaBritt E Heidemann, Charlotte Koopal, Jeanine E Roeters van Lennep, et al.
Journal of Clinical Lipidology|July 30, 2023
Composition and distribution of lipoproteins after evolocumab in familial dysbetalipoproteinemia: A randomized controlled trialBritt E Heidemann, A David Marais, Monique T Mulder, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|August 23, 2000
WHO consensus conference on diet and cancer. Members of the breast cancer panelF L Meyskens, W F Jungi, M Gerber, et al.
Atherosclerosis|March 23, 2022
Genetic variants associated with low-density lipoprotein cholesterol and systolic blood pressure and the risk of recurrent cardiovascular disease in patients with established vascular diseaseEline H Groenland, Britt E Heidemann, Sander W van der Laan, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2002
Primary breast cancer therapy in six regions of GermanyJ Engel, G Nagel, E Breuer, et al.
Breast Cancer Research and Treatment|December 10, 2015
Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotypeWerner Schroth, S Winter, F Büttner, et al.
Clinical Genetics|July 5, 2022
Establishing the relationship between familial dysbetalipoproteinemia and genetic variants in the APOE geneBritt E Heidemann, Charlotte Koopal, Alexis Baass, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trialE Heidemann, H Stoeger, R Souchon, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 9, 2022
Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol measurement in Familial DysbetalipoproteinemiaBritt E Heidemann, Charlotte Koopal, Jeanine E Roeters van Lennep, et al.
Journal of Clinical Lipidology|November 17, 2022
Effect of evolocumab on fasting and post fat load lipids and lipoproteins in familial dysbetalipoproteinemiaBritt E Heidemann, Charlotte Koopal, Jeanine E Roeters van Lennep, et al.
Journal of Clinical Lipidology|July 30, 2023
Composition and distribution of lipoproteins after evolocumab in familial dysbetalipoproteinemia: A randomized controlled trialBritt E Heidemann, A David Marais, Monique T Mulder, et al.
Pageof 7